Breadcrumb
- Home
- IDDI Workstreams & Task Forces
- Lung Transplantation In Pulmonary Hypertension Wor...
Lung Transplantation in Pulmonary Hypertension Workstream
The newest addition to the IDDI, this Workstream has hit the ground running! Since its inaugural meeting in June 2023, it has been addressing global access to transplant across different allocation systems and transplant programmes.
The Workstream’s membership includes representatives from Australia, Europe and the United States. Together, they’ve identified the key issues in LTX using a Delphi consensus process that was presented at PVRI 2024 London, and an update was presented at WSPHA in summer 2024. The group has also produced two manuscripts on peri- and post-operative issues in transplantation.
We’re particularly excited about their new project, which will help connect PAH centres with transplant programmes worldwide to ensure that PH patients have better access to transplants.
Publications
- Kolaitis, N. A., Barnes, H., Levine, D. J., Castillo, H., Arcasoy, S. M., et al. (2025) ‘Approach to lung transplantation in pulmonary arterial hypertension: A Delphi consensus on behalf of the Transplant Task Force of the Pulmonary Vascular Research Institute’. Pulmonary Circulation, 15(2), e70088
Webinars
- Paediatric Bridge to Transplant, July 2025
- Debunking myths about lung transplantation for PH – A webinar for patients and caregivers featuring presentations by clinicians and patients, September 2024
The Workstream meets on the last Friday of every month at 15:00 BST/GMT. If you are interested in joining this Workstream, please get in touch.
Leaders
IDDI Workstreams and Task Forces
Want to be part of something special?
All PVRI members are welcome to join an IDDI Workstream or a Task Force.
Interested in accessing global data on PH patient experience?
Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
Our Regional Task Forces don't yet have global coverage. If you're interested in starting one, please contact us.